This is the first stem cell trial in acute myocardial infarction (AMI)ever conducted that has prospectively established a significant relationship between dose and effect.
Stem cell drug (AMR-001) to treat damage heart muscle successfully completed Phase I clinical trials
WASHINGTON - American scientists have created a “switch” that allows mutations or light signals to be turned on in muscle stem cells to monitor muscle regeneration in a living mammal.
WASHINGTON - Researchers at St. Jude Children’s Research Hospital have found that eye cells believed to be retinal stem cells are actually normal adult cells, and thus therapies to restore vision in people with retinal degeneration should involve other types of stem cells.
Recent adult stem cell trials(phase I) on type 2 diabetic patients are showing encouraging results. The new treatment shows the ability to produce natural insulin inside the body and thus really offers positive hope to the 24 millions of Americans who are suffering from the killer disease.
Embryonic stem cell derived Mesenchymal stem cells will be available commercially : announces ArunA Biomedical
Hopefully from the mid of this year(2009) scientists can just go and buy Mesenchymal Stem Cells from ArunA Biomedical, Inc. when ever required.
LONDON - British scientists are on their way to provide double bonanza to women looking for boob-jobs: a stem cell therapy that offers “natural” breast enlargement - and cuts stomach or thigh fat in the process.
BANGALORE - Narayana Health City, a hospital in Bangalore, has come-up with a public stem cell bank named the Rotary Narayana Tissue Bank and Stem Cell Research Centre.
ChemGenex Pharmaceuticals announced on March 26th, 2009 through online publication in the journal Leukemia, about the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML).
An important discovery reported on Wednesday, March 25 by researchers at the National Institutes of Health (NIH; www.nih.gov).
Cardium Therapeutics reported today that researchers at the University of Cincinnati on a NIH funded pre clinic study able to potentiate Mesenchymal Stem Cells to accelerate bone marrow stem cell mobilization via paracrine activation to promote myocardial Repair.